Shopping Cart
Remove All
Your shopping cart is currently empty
Zalifrelimab (AGEN1884) is a fully human IgG1 monoclonal antibody that targets CTLA-4, antagonizing the CTLA-4-signaling-regulated inhibitory checkpoints of immune cell activation.
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $247 | - | In Stock | |
| 5 mg | $647 | - | In Stock | |
| 10 mg | $987 | - | In Stock |
| Description | Zalifrelimab (AGEN1884) is a fully human IgG1 monoclonal antibody that targets CTLA-4, antagonizing the CTLA-4-signaling-regulated inhibitory checkpoints of immune cell activation. |
| Reactivity | Human |
| Application | FACS Functional assay |
| Antibody Type | Monoclonal |
| Endotoxin | <1.0 EU/mg |
| Conjucates | Unconjugated |
| Uniprot ID | |
| Target | CTLA-4 |
| Molecular Weight | 144.32 KDa |
| Cas No. | 2148321-69-9 |
| Color | Transparent |
| Appearance | Liquid |
| Isotype | Human IgG1 kappa |
| Recommended Isotype Control |
| Storage | store at low temperature | -20°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.